Vor Biopharma Stock Forecast
Fda fast track designation for acute myeloid leukemia. The average price target represents a 290.93% upside from the last price of $11.98.
Vor biopharma inc () stock market info recommendations:
Vor biopharma stock forecast. See what signals are being triggered and find all the latest price data and stock quotes for the vor stock. Buy or sell vor biopharma stock? Vor biopharma insider sold over $5.0m in company stock.
Vor biopharma inc stock price forecast for further price development up to 3.79% (time horizon: At that level they are trading at 0.188% discount to the analyst consensus target price of 0.00. The average price target represents a 164.85% from the last price of $21.71.
Wall street stock market & finance report, prediction for the future: Investorsobserver gives vor biopharma inc (vor) an overall rank of 47, which is below average. The reported ($0.50) earnings per share (eps) for the quarter, topping the consensus estimate of ($0.62) by $0.12.
The primary goals of the trial are to evaluate tolerability and feasibility of the vor33 stem cell transplant, with a focus on confirming that vor33 can engraft normally. Vor biopharma promotes tirtha chakraborty to chief scientific officer. Stock was originally listed at a price of $42.83 in feb 8, 2021.
Puretech health plc noted that its founded entity, vor biopharma announced that the u.s. Vor biopharma has generated $0.00 earnings per share over the last year. 1 day) and price target of 14.10 usd.
Based on 2 wall street analysts offering 12 month price targets for vor biopharma in the last 3 months. A rank of 47 means that 53% of stocks appear more favorable to our system. Trend forecast is still in the development phase and should be used with caution.
The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. The highest, average, and lowest price. Vor announces fda clearance of ind application for vor33.
Vor biopharma announces vor33 granted u.s. Earnings for vor biopharma are expected to decrease in the. Find the latest vor biopharma inc.
Analyst estimates, including vor earnings per share estimates and analyst recommendations. You'll find the vor biopharma share forecasts, stock quote and buy / sell signals below.according to present data vor biopharma's vor shares and potentially its market environment have been in bearish cycle last 12 months (if exists). This price target is based on 6 analysts offering 12 month price targets for vor biopharma in the last 3 months.
Shares in vor biopharma inc are currently priced at $17.94. The average price target is $46.83, with a high forecast of $60.00 and a low forecast of $19.00. Some cases might produce unexpected.
This chart shows the closing price for vor for the. Holds several positive signals, but we still don't find these to be enough for a buy candidate. Food and drug administration has granted fast track designation to vor33, vor’s lead engineered hematopoietic stem cell therapeutic candidate for the treatment of acute myeloid leukemia.
Analyst price target on vor. Stock forecast get free stock nasdaq:vor. 5, 2021 at 10:48 a.m.
The average price target is $57.50 with a high forecast of $60.00 and a low forecast of $55.00. Press releases archives » vor biopharma. Is estimated to report earnings on 11/08/2021.
On average, wall street analysts predict that. Vor biopharma's share price could stay at $45.00 by oct 19, 2022. Vor biopharma last released its earnings data on november 10th, 2021.
At the current level, it should be co. The average vor biopharma stock price prediction forecasts a potential downside of n/a from the current vor share price of $12.48. Vor biopharma stock indicated to open around $36, or double the $18 ipo price.
Kush parmar, insider at vor biopharma (nasdaq:vor), made a large insider sell on november 16, according to a. Vor biopharma inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.
Post a Comment for "Vor Biopharma Stock Forecast"